BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.09.24 Share Price

Warrant

DE000VM7N4X7

Market Closed - Deutsche Boerse AG 19:01:06 10/05/2024 BST
0.94 EUR +1.08% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.09.24
Current month-3.09%
1 month+13.25%
Date Price Change Volume
10/05/24 0.94 +1.08% 0
09/05/24 0.93 +2.20% 0
08/05/24 0.91 +5.81% 0
07/05/24 0.86 +10.26% 0
06/05/24 0.78 -2.50% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 07:01 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7N4X
ISINDE000VM7N4X7
Date issued 29/12/2023
Strike 125 $
Maturity 20/09/2024 (131 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.23
Lowest since issue 0.222
Spread 0.01
Spread %1.08%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus